What is Patient21 SE?
Patient21 SE is a healthcare technology company dedicated to enhancing the doctor-patient relationship by removing obstacles to effective care. The company champions deep collaboration across medical specialties and universal access to health data, aiming to empower both patients and doctors in making informed decisions. Recognizing that healthcare systems often lag behind in digital integration, Patient21 SE leverages data analytics and a network of experts to provide personalized treatments and a holistic view of patient health, thereby bringing healthcare into the 21st century.
How much funding has Patient21 SE raised?
Patient21 SE has raised a total of $108M across 1 funding round:
Series C
$108M
Series C (2023): $108M with participation from Target Global, The Artian, IPF Partners, and Pitango
Key Investors in Patient21 SE
Target Global
Target Global is a leading pan-European technology investment firm with a significant portfolio, investing across all stages of company lifecycles. Their expertise lies in backing disruptive tech companies, providing strategic capital and operational support to entrepreneurs.
The Artian
The Artian is a Creative Leadership Development Atelier focused on nurturing creative leaders through bespoke programs. They blend artistic imagination with entrepreneurial execution to foster growth and innovation within organizations.
IPF Partners
IPF Partners is a specialized alternative financing provider exclusively for the healthcare sector, offering tailored debt and equity solutions to commercial-stage digital health, biopharma, and healthcare services companies.
What's next for Patient21 SE?
The substantial enterprise-level funding, including the recent strategic investment, positions Patient21 SE for accelerated expansion and innovation. This capital infusion is expected to fuel the company's mission to integrate advanced data analytics and collaborative tools into healthcare workflows. Future developments will likely focus on scaling its network, enhancing its data-driven personalization capabilities, and further solidifying its role as a catalyst for digital transformation in the healthcare industry. The company's strategic backing suggests a focus on achieving significant market penetration and technological advancement.
See full Patient21 SE company page
